REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $153,850 | +14.2% | 12,736 | 0.0% | 0.00% | – |
Q2 2023 | $134,746 | +162.8% | 12,736 | +144.5% | 0.00% | – |
Q1 2023 | $51,266 | -24.8% | 5,210 | +12.5% | 0.00% | – |
Q4 2022 | $68,151 | +19.6% | 4,633 | 0.0% | 0.00% | – |
Q3 2022 | $57,000 | -12.3% | 4,633 | 0.0% | 0.00% | – |
Q2 2022 | $65,000 | +16.1% | 4,633 | +18.1% | 0.00% | – |
Q1 2022 | $56,000 | -32.5% | 3,923 | 0.0% | 0.00% | – |
Q4 2021 | $83,000 | +23.9% | 3,923 | +55.5% | 0.00% | – |
Q3 2021 | $67,000 | +204.5% | 2,523 | +257.4% | 0.00% | – |
Q2 2021 | $22,000 | 0.0% | 706 | 0.0% | 0.00% | – |
Q1 2021 | $22,000 | +37.5% | 706 | +41.2% | 0.00% | – |
Q2 2020 | $16,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |